LM-22A-4

N/A

Report date: 2024/11/18 15:23:33
NME

Base Information

Drug NameLM-22A-4
Drug Alias NameLM22A-4LM-22-A-4LM-22A-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulants
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsAlzheimer DiseaseBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, San Francisco Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California, San Francisco Foundation
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A